Related Experiment Videos
The Premorbid Adjustment Scale (PAS): its use in an Australian study
The Australian and New Zealand Journal of Psychiatry
|December 1, 1985
Summary
The Premorbid Adjustment Scale (PAS) shows promise in distinguishing schizophrenia from mania. However, further research is needed to confirm its utility in predicting schizophrenia patient outcomes.
Area of Science:
- Psychiatry
- Psychometrics
- Clinical Psychology
Background:
- The Premorbid Adjustment Scale (PAS) is a newly developed instrument for assessing premorbid functioning in schizophrenia.
- The National Institute of Mental Health (NIMH) developed the PAS for schizophrenia research and clinical practice.
Purpose of the Study:
- To describe the use of the PAS in an Australian study.
- To evaluate the discriminative validity and reliability of the PAS.
- To assess the predictive validity of the PAS regarding hospitalization duration in schizophrenia.
Main Methods:
- The Premorbid Adjustment Scale (PAS) was administered.
- Total PAS scores were analyzed to discriminate between schizophrenic and manic patients.
- Test-retest reliability of the PAS was assessed in schizophrenic patients.
- The relationship between PAS scores and duration of hospitalization was examined in schizophrenic patients.
Main Results:
- Total PAS scores effectively discriminated between patients with schizophrenia and those with mania.
- The PAS demonstrated good test-retest reliability among schizophrenic patients.
- PAS scores did not predict the duration of hospitalization for schizophrenic patients, consistent with previous North American findings.
Conclusions:
- The Premorbid Adjustment Scale (PAS) shows potential for differentiating schizophrenia from mania and has good reliability.
- The PAS's ability to predict hospitalization duration in schizophrenia requires further investigation.
- Additional research is necessary to establish the PAS as a validated instrument for schizophrenia research and clinical application.